Jiangsu Nanfang Medical Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 523.74 million compared to CNY 1,071.36 million a year ago. Revenue was CNY 527.44 million compared to CNY 1,072.4 million a year ago. Net loss was CNY 22.76 million compared to net income of CNY 98.07 million a year ago. Basic loss per share from continuing operations was CNY 0.0778 compared to basic earnings per share from continuing operations of CNY 0.3426 a year ago. Diluted loss per share from continuing operations was CNY 0.0778 compared to diluted earnings per share from continuing operations of CNY 0.3426 a year ago.